Linezolid/unspecified opioids interactionSerotonin syndrome following drug-drug interaction: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1890卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09152-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：155 / 155

相关论文

共 50 条

[31] Multiple drugsSerotonin syndrome following drug-drug interaction
[J]. Reactions Weekly, 2024, 2007 (1) : 258 - 258
[32] Droperidol/olanzapine interactionExtrapyramidal symptoms following drug-drug interaction: case report
[J]. Reactions Weekly, 2022, 1908 (1) : 230 - 230
[33] Multiple drugsDeath following overdose, poisoning and drug-drug interaction: case report
[J]. Reactions Weekly, 2023, 1967 (1) : 251 - 251
[34] Multiple drugsPancytopenia following misuse and drug-drug interaction and gout: case report
[J]. Reactions Weekly, 2021, 1859 (1) : 250 - 250
[35] Insulin/ipatasertibHyperglycaemia, and inuslin resistance following drug-drug interaction: case report
[J]. Reactions Weekly, 2022, 1914 (1) : 262 - 262
[36] Multiple drugsEuglycaemic diabetic ketoacidosis following drug-drug interaction: case report
[J]. Reactions Weekly, 2021, 1852 (1) : 294 - 294
[37] Azathioprine/febuxostat interactionAnaemia and leucopenia following drug-drug interaction: case report
[J]. Reactions Weekly, 2021, 1848 (1) : 77 - 77
[38] Citalopram/linezolid interactionVisual hallucinosis following drug interaction: case report
[J]. Reactions Weekly, 2023, 1975 (1) : 116 - 116
[39] Risperidone/Sertraline/TrazodoneSerotonin syndrome and drug-drug pharmacokinetic interaction : case report
[J]. Reactions Weekly, 2024, 2019 (1) : 405 - 405
[40] Amenamevir/quetiapine interactionDecreased drug level in blood following drug-drug interaction: case report
[J]. Reactions Weekly, 2023, 1947 (1) : 31 - 31

← 1 2 3 4 5 →